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Abstract
 
Carma1 (also known as caspase recruitment domain [CARD]11, Bimp3) is a CARD-containing
membrane-associated guanylate kinase family protein that plays an essential role in antigen receptor–
induced nuclear factor 
 
 
 
B activation. We investigated the role of Carma1 in the assembly of
signaling molecules at the immune synapse using a peptide-specific system. We report that
Carma1 is essential for peptide-induced interleukin 2 and interferon 
 
  
 
production, but dispens-
able for proliferation in T cells. Recruitment and distribution of T cell receptor, lymphocyte
function associated 1, lipid rafts, and protein kinase C (PKC)
 
  
 
to central and peripheral immune
synapse regions occur normally in 
 
Carma1
 
 
 
/
 
  
 
T cells. Carma1 controls entry of I
 
 
 
B kinase (IKK)
into lipid raft aggregates and the central region of the immune synapse, as well as activation of
IKK downstream of PKC. Our data provide the first genetic evidence on a new class of molecular
scaffold that controls entry of defined signaling components, IKK, into the central supramolecular
activation cluster at T cell–antigen-presenting cell interfaces without having any apparent effect
on the overall organization and formation of immune synapses.
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Introduction
 
T cell activation depends on contact between TCRs and
agonistic peptide displayed by MHC expressed on APCs.
TCR-mediated stimulation results in the assembly of anti-
gen receptors, signaling molecules, and lipid rafts to form
supramolecular activation clusters (SMACs) at the inter-
face of physical contact between T cells and APCs (1).
Based on the structural similarity to synapses in the ner-
vous system, SMACs are also referred to as immune syn-
apses (2–4). SMAC segregate into a central core, the cen-
tral SMAC (cSMAC), where the TCR and protein kinase
C (PKC)
 
  
 
are colocalized and lipid rafts preferentially ac-
cumulate, and a peripheral zone, the peripheral SMAC
(pSMAC), which includes LFA-1 and talin (1, 5). The
physiological importance of immune synapse formation
has been demonstrated by a line of evidence that shows
deficiency of proteins such as Vav1 that affect intact im-
mune synapse formation results in impaired T cell activa-
tion (6–10).
Membrane-associated guanylate kinase (MAGUK) family
proteins control the polarity of membrane domains at epi-
thelial cell junctions and play critical roles in synaptic develop-
ment and plasticity (11–14). Because immune and neuronal
synapses share structural similarities (3, 4), it has been spec-
ulated that MAGUK family proteins have a function in the
formation and/or organization of the immune synapse in lym-
phocytes. Carma1/caspase recruitment domain (CARD)11/
Bimp3 is a CARD-containing MAGUK family protein that
is abundantly expressed in lymphoid tissues. Using gene
targeting, we and others have recently demonstrated that
Carma1 is essential for TCR-induced activation of T cells
(15–18). However, it is not known whether Carma1 is essen-
tial to form the immune synapse.
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The recognition of pathogens by innate or adaptive im-
mune receptors leads to activation of the NF-
 
 
 
B family of
transcription factors (19). NF-
 
 
 
B proteins are present in the
cytoplasm in association with inhibitory proteins known as
inhibitor of NF-
 
 
 
Bs (I
 
 
 
Bs). The signals generated by acti-
vated receptors result in phosphorylation of I
 
 
 
B proteins.
Phosphorylated I
 
 
 
B proteins become targets for ubiquitina-
tion and proteasome-mediated degradation, allowing NF-
 
 
 
B
to translocate to the nucleus. Phosphorylation of I
 
 
 
B is me-
diated by the I
 
 
 
B kinase (IKK) complex, consisting of two
catalytic subunits, IKK1/
 
  
 
and IKK2/
 
 
 
, and the NEMO/
IKK
 
  
 
regulatory subunit (20,21). Therefore, the understand-
ing of NF-
 
 
 
B regulation and function is tightly linked to the
understanding of IKK regulation and function (22).
Activation of NF-
 
 
 
B mediated by TCR and CD28 co-
stimulation is essential for activation, expansion, and effec-
tor functions of T cells (19, 23). PKC
 
  
 
integrates the TCR
and CD28 signals that lead to NF-
 
 
 
B activation, and after
T cell activation, PKC
 
  
 
translocates to lipid rafts at the im-
mune synapse (24–26). Importantly, among the several
isoenzymes expressed in T cells, it appears that PKC
 
  
 
is the
only PKC isoform that translocates to the immune synapse
(1). Genetic approaches have confirmed that PKC
 
  
 
is a
component in the TCR-induced NF-
 
 
 
B activation path-
way because T cells from PKC
 
 
 
 
 
/
 
  
 
mice cannot be acti-
vated in response to antigen and display impaired NF-
 
 
 
B
activation (27). Other essential components in this pathway
are Bcl10, MALT1, and Carma1 (15–18, 28, 29). These
three molecules interact with each other and seem to form
a signalosome to activate NF-
 
 
 
B (30–32). Recent reports
have shown that the IKK complex translocates to lipid rafts
at the immune synapse after TCR/CD28 or PMA/iono-
mycin stimulation and this localization is sufficient to in-
duce NF-
 
 
 
B activation (33, 34). These findings suggested
that the recruitment of IKK into the lipid rafts is a key
event to connect IKK to upstream components. However,
the exact molecular mechanisms that control the recruit-
ment of IKK into lipid rafts are not yet defined. Moreover,
despite the similarity in function and phenotype of knock-
out mice, the mechanistic connections between PKC
 
 
 
,
Carma1, Bcl10, and IKK remain unclear.
Because data on Carma1-regulated NF-
 
 
 
B activation
were based on antibody cross-linking studies, we analyzed
the role of Carma1 in peptide–APC-induced T cell activa-
tion and assembly of the immune synapse. We show that
 
Carma1
 
 
 
/
 
  
 
T cells can still proliferate but display markedly
abrogated cytokine production when activated by specific
peptides. This is not due to defects in the immune synapse
formation between T cells and APCs, nor due to defective
recruitment of PKC
 
  
 
to the synapse. Moreover, peptide-
induced cell adhesion and LFA-1 accumulation at the im-
mune synapse appear normal. Intriguingly, Carma1 was
found to be essential for recruitment of IKK into the cen-
tral region of the immune synapse. Moreover, genetic inac-
tivation of Carma1 completely abolishes PKC-dependent
IKK recruitment to aggregated lipid rafts and IKK activa-
tion. We also show that Bcl10 and IKK recruitment to
lipid rafts is independently regulated. Thus, the MAGUK
family protein Carma1 is the first molecular adaptor identi-
fied in vivo that couples antigen receptor signaling to the
assembly of supramolecular signaling complexes down-
stream of immune receptor and lipid raft clustering.
 
Materials and Methods
 
Mice. Carma1
 
 
 
/
 
  
 
mice have been described (16). BALB/c
mice and DO11.10 TCR transgenic (Tg; DO11.10-Tg) were
purchased from The Jackson Laboratory. DO11.10-Tg/
 
Carma1
 
 
 
/
 
 
 
mice congenic for I-A
 
d 
 
were made by crossing DO11.10-Tg mice
with 
 
Carma1
 
 
 
/
 
  
 
mice and were backcrossed for three generations
into a BALB/c background. DO11.10 Tg
 
/Carma1
 
 
 
/
 
  
 
mice were
then intercrossed to generate DO11.10-Tg/
 
Carma1
 
 
 
/
 
  
 
and con-
trol DO11.10-Tg/
 
Carma1
 
 
 
/
 
  
 
mice. The expression of I-A
 
d 
 
and
DO11.10-TCR was determined by flow cytometric analysis of
peripheral blood cells using specific antibodies.
 
T Cell Responses.
 
Lymph node CD4
 
  
 
T cells were purified
from DO11.10-Tg mice using magnetic beads (Dynal) to remove
CD8
 
 
 
, B220
 
 
 
, Mac-1
 
 
 
, and Gr-1
 
  
 
cells. 5 
 
  
 
10
 
4 
 
purified CD4
 
 
 
T cells (
 
 
 
95% CD4
 
  
 
by FACS) were stimulated for 48 h with 10
 
 
 
g/ml mitomycin c (Sigma-Aldrich) –treated A20 B lymphoma
cells (3 
 
  
 
10
 
4
 
; derived from BALB/c mice) as APCs in the
presence or absence of various doses of OVA
 
323–339 
 
peptide
(ISQAVHAAHAEINEAGR; reference 35) in 96-well plates in
RPMI 1640 media supplemented with 10% FCS and 10
 
 
 
5 
 
M
 
 
 
-mercaptoethanol. Cells were stimulated in triplicate followed
by an 8-h pulse with 1 
 
 
 
Ci per well of [
 
3
 
H]thymidine (Amer-
sham Biosciences) to determine proliferation. Culture superna-
tants were assayed in triplicate for the production of IL-2, IL-4,
and IFN-
 
  
 
by ELISA (R&D Systems).
 
Conjugate Formation and Cell Adhesion.
 
Unless otherwise in-
dicated, A20 B lymphoma cells were loaded with 10
 
 
 
6 
 
M of
OVA
 
323–339 
 
peptide for 4 h at 37
 
 
 
C. 10
 
6 
 
lymph node CD4
 
  
 
T cells
and peptide-loaded or nonloaded APCs (A20 B cells) were then
mixed at a 1:1 ratio, centrifuged briefly to promote conjugate
formation, and incubated at 37
 
 
 
C for different times in serum-
free medium. The reactions were stopped and cells were fixed by
adding 4% paraformaldehyde. Cell conjugates were stained with
anti-DO11.10 TCR PE (BD Biosciences) and anti-B220 APC
(BD Biosciences) to detect T cells and APCs, respectively. The
percentages of T–APC conjugates (DO11.10 TCR and B220
double positive cells) were analyzed by flow cytometry.
 
Immunofluorescence Confocal Microscopy.
 
Primary T lympho-
blasts were made by culturing CD4
 
  
 
T cells with 10
 
 
 
6 
 
M pep-
tide-pulsed A20 APCs for 2 d followed by an additional 4-d cul-
ture in the presence of 50 U/ml of rmIL-2 (R&D Systems)
without antigen stimulation. For peptide-specific stimulation,
CD4
 
  
 
T cells or the primary T lymphoblasts from DO11.10-Tg/
 
Carma1
 
 
 
/
 
 
 
, 
 
Carma1
 
 
 
/
 
 
 
, and 
 
Carma1
 
 
 
/
 
  
 
mice were stained with 5
 
 
 
g/ml Alexa Fluor 488 cholera toxin (CTx; Molecular Probes),
and then incubated with peptide-pulsed APCs (A20 B cells) as
described above. CTx specifically binds to the lipid raft enriched
in glycosphingolipid GM-1 (5, 36). For raft cross-linking experi-
ments, Alexa Fluor 488 CTx–stained T cells were incubated with
4 
 
 
 
g/ml goat anti-CTx (Calbiochem) and 50 ng/ml PMA plus
100 ng/ml calcium ionophore for 10 min at 37
 
 
 
C. Cells were
fixed with 4% paraformaldehyde, transferred onto slides using
cytospin, and permeabilized with 0.1% Triton X-100 in PBS.
Cells were then stained with rabbit anti-PKC
 
  
 
(C-18; Santa Cruz
Biotechnology, Inc.), anti-Bcl10 mAb (331.3; Santa Cruz Bio-
technology, Inc.), rabbit anti-IKK
 
 
 
/
 
  
 
(H-470; Santa Cruz Bio- 
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technology, Inc.), anti-IKK
 
  
 
(C73-764; BD Biosciences), anti–
LFA-1 (M17/4; BD Biosciences), biotinylated anti-DO11.10
TCR mAb (Caltag), and Texas red–conjugated phalloidin (Mo-
lecular Probes). Goat anti–rabbit, anti–rat, or anti–mouse IgG
secondary antibodies conjugated to Alexa Fluor 594 or Alexa
Fluor 633 (Molecular Probes) were used to visualize the primary
antibodies. For biotinylated antibodies, Alexa Fluor 594–conju-
gated streptavidin (Molecular Probes) was used. Confocal images
were obtained using an Olympus 1X-70 inverted microscope
equipped with fluorescence optics and Deltavision Deconvolu-
tion Microscopy software (Applied Precision). For the detection
of cSMACs and pSMACs, fixed cells were stained with rat anti–
LFA-1 (M17/4; BD Biosciences) and rabbit anti-PKC
 
  
 
or rabbit
anti-IKK
 
 
 
/
 
 
 
, followed by staining with Alexa Fluor 568–conju-
gated goat anti–rabbit IgG and Alexa Fluor 633–conjugated goat
anti–rat IgG, respectively. Confocal images of T–APC interfaces
were obtained and analyzed using confocal scanning microscopy.
 
Kinase Assays.
 
Purified lymph node CD4
 
  
 
T cells were stim-
ulated with 50 ng/ml PMA plus 100 ng/ml calcium ionophore
as described above. After immunoprecipitation with anti-IKK
(M-280; Santa Cruz Biotechnology, Inc.), IKK activity was as-
sayed using 3 
 
 
 
g of recombinant GST-I
 
 
 
B
 
  (amino acids 1–54)
as a substrate as described previously (37).
Flow Cytometry. Cells were stained with FITC-, PE-, and
APC-conjugated antibodies. For analysis of surface antigen ex-
pression, the following antibodies were used: anti-CD3 APC,
anti-DO11.10 TCR PE, anti-CD4 FITC, anti-CD4 PE, anti-
CD28 FITC, and anti–LFA-1 PE. All antibodies were purchased
from BD Biosciences. Samples were analyzed by flow cytometry
using a FACScan (Becton Dickinson).
Cellular Fractionation. Cellular fractionations were performed as
described previously (33). In brief, 107 purified lymph node T cells
were left untreated or stimulated with 50 ng/ml PMA plus 100 ng/
ml calcium ionophore. Cells were lysed on ice for 30 min in 1 ml of
NP-40 lysis buffer (1% NP-40, 10 mM Tris, pH 7.4, 10 mM KCl,
1.5 mM MgCl2, 1 mM Na3VO4, and protein inhibitors), and then
homogenized with a Dounce homogenizer (20 strokes) and spun at
500 g for 7 min at 4 C. The postnuclear supernatant was centrifuged
at 100,000 g for 1 h at 4 C and the supernatant, referred to as the
detergent-soluble membrane and cytosolic fraction (S), was col-
lected. The pellet was rinsed once in the NP-40 lysis buffer and sol-
ubilized in 100  l of RIPA buffer (20 mM Tris, pH 7.5, 250 mM
NaCl, 10 mM DTT, 10 mM MgCl2, 1% NP-40, 0.1% SDS, 0.5%
sodium deoxycholate, and protein inhibitors), and the insoluble ma-
terial was removed by centrifugation for 10 min at 10,000 g. This
preparation was designated as detergent insoluble material (DIM).
25- l aliquots of each fraction were resolved by SDS-PAGE and
analyzed by Western blotting using antibodies specific for anti-
IKK   mAb (14A231; Upstate Biotechnology) and anti-PKC 
(C-18; Santa Cruz Biotechnology, Inc.). For quantification of ex-
pression levels, Western blot images were scanned and the intensity
of bands was quantified using IPLab Gel (Signal Analytics).
Online Supplemental Material. Fig. S1 shows defective recruit-
ment of IKK into lipid rafts at the immune synapse in naive
Carma1 /  CD4  T cells. Fig. S2 shows defective subcellular
translocation of IKK from detergent-soluble fractions to deter-
gent-insoluble membrane fractions in Carma1 /  T cells after
PMA plus calcium ionophore stimulation. Fig. S3 shows a sche-
matic model of the role for Carma1 in the TCR-mediated NF-
 B pathway. Figs. S1–S3 are available at http://www.jem.org/
cgi/content/full/jem.20032246/DC1.
Results
Carma1 Is Essential for Cytokine Production, But Not Prolif-
eration of Peptide-stimulated T Cells. We and others have
previously shown that Carma1 /  T cells are markedly im-
Figure 1. Carma1 is essential for
peptide-specific cytokine production,
but not proliferation of T cells. (A)
Expression levels of CD3, CD4, the
clonotypic DO11.10 TCR, LFA-1,
and CD28 on lymph node CD4  T
cells purified from DO11.10 Tg/
Carma1 /   and DO11.10 Tg/
Carma1 /   mice. Data from gated
CD4  T cells are shown. (B–D) Pro-
liferation and cytokine production in
the absence of Carma1. Purified
CD4  T cells from DO11.10 Tg/
Carma1 /   and DO11.10 Tg/
Carma1 /   were stimulated with
A20 APCs pulsed with various con-
centration of OVA323–339  peptide.
Culture supernatants were harvested
40 h after stimulation and levels of
(B) IL-2 and (C) IFN-  production
were determined by ELISA. (D) Pro-
liferation was assessed at 48 h by
[3H]thymidine incorporation. Values
are mean   SD for triplicate culture.
Results are representative of three
independent experiments.Carma1 Controls IKK Recruitment into cSMAC 1170
paired both in proliferation and IL-2 production in re-
sponse to anti-CD3  antibody cross-linking and anti-CD3 /
CD28 stimulation (14–17). To examine the role of Carma1
in antigen-specific responses of T cells, we bred the Carma1
mutation on DO11.10-Tg mice to generate DO11.10-
Tg/Carma1 /  and DO11.10-Tg/Carma1 /  mice. The
DO11.10 TCR transgene is specific for the OVA323–339
peptide in association with MHC class II (I-Ad). The popu-
lations of CD4  DO11.10 TCR Tg T cells were similar
between Carma1 /  and Carma1 /  mice (not depicted).
Moreover, we could not find any significant changes in the
cell surface expression levels of the clonogenic DO11.10
antigen receptor, CD3 , CD4, CD28, or the integrin
LFA-1 between DO11.10-Tg/Carma1 /  and DO11.10-
Tg/Carma1 /  mice (Fig. 1 A). Thus, as described previ-
ously for the HY-TCR (16), genetic inactivation of
Carma1 has no apparent effect on the development, popu-
lations, or expression levels of surface receptors in DO11.10
TCR Tg mice.
To determine the function of Carma1 in antigen-spe-
cific responses, purified lymph node CD4  T cells from
DO11.10-Tg/Carma1 /  and DO11.10-Tg/Carma1 /  mice
were stimulated with A20 B cells as APCs pulsed with dif-
ferent doses of the OVA323–339 peptide. As expected from
Figure 2. Immune synapse
formation and peptide-specific
cell adhesion in Carma1     T
cells. (A) DIC images of T cell–
A20-APC conjugates. Localiza-
tion of lipid rafts (green) and
DO11.10 TCR (red) are shown.
Yellow in the merged images in-
dicates colocalization of the TCR
with lipid raft. (B and C) Local-
ization of (B) polymerized actin
(F-actin; visualized with phalloi-
din) and (C) LFA-1 at the focal
contact sites. (D) Percentages (per-
cent     SD) of DO11.10 TCR,
lipid rafts, F-actin, and LFA-1
clustered at the immune synapse.
(A–D) Purified lymph node
CD4  T cells from DO11.10 Tg/
Carma1 /   and DO11.10 Tg/
Carma1 /  were labeled with Al-
exa Fluor 488 CTx, and then in-
cubated with 10 6 M OVA323–339
peptide–pulsed A20 cells for 30
min. At least 100 cells were
counted for each sample. Results
are representative of three inde-
pendent experiments. T, T cell;
A20, A20 APCs. (E) Peptide-
specific cell adhesion assay. A20
APCs and DO11.10-Tg T cells
are distinguishable by their ex-
pression of B220 and DO11.10
TCR (top). Purified CD4  T cells
from DO11.10 Tg/Carma1 / 
and DO11.10 Tg/Carma1 / 
were mixed with 10 6  M
OVA323–339  peptide–pulsed or
nonpulsed control A20 APCs
and incubated for 30 min (middle
and bottom), and T cell–APC
conjugates were detected as
DO11.10 TCR and B220 double
positive cells. (F) Percentages of
DO11.10 Tg T cells that form
conjugates with APCs loaded
with various OVA323–339 peptide
doses. Conjugate formation was
assayed at 30 min. (G) Conjugates
were monitored over different
time periods using APCs loaded
with 10 6  M OVA323–339  pep-
tide. Results are representative of
three independent experiments.Hara et al. 1171
previous antibody cross-linking data (15, 16), IL-2 and
IFN-  production was completely abrogated in Carma1 / 
T cells (Fig. 1, B and C). IL-4 production could not be de-
tected in both wild-type and Carma1 /  DO11.10-Tg T cells
under the same stimulation conditions. These defects in cy-
tokine production could not be overcome even at high
doses of peptide stimulations, indicating that Carma1 is es-
sential for peptide-induced cytokine productions of T cells.
Surprisingly, although proliferative responses of DO11.10-
Tg/Carma1 /  T cells were impaired at lower peptide stim-
ulation up to 10 8 M, higher doses of peptide stimulation
restored their response to levels that were comparable to
that of control DO11.10-Tg/Carma1 /  T cells (Fig. 1 D).
These results indicate that Carma1-mediated signaling is es-
sential for cytokine productions, but dispensable for prolif-
eration of T cells in response to specific peptide plus APCs.
Carma1 Is Not Involved in the Formation of the Immune Syn-
apse. It has been reported that Carma1 is recruited to the
immune synapse and becomes associated with the antigen
receptor complex after TCR stimulation (38). Antigen re-
ceptor stimulation in T cells results in TCR clustering at the
immune synapse, reorganization of the actin cytoskeleton at
the site of assembled TCRs, and clustering of integrins (39).
In addition, lipid rafts are also assembled at the immune syn-
apse and membrane receptors including TCR and many in-
tracellular signaling molecules are recruited to lipid rafts dur-
ing T cell activation (36, 40). Thus, similar to the function
of other MAGUK family proteins in neuronal synapse, we
speculated that lack of Carma1 could affect immune synapse
formation in T cells. Therefore, we examined whether loss
of Carma1 in T cells results in defective formation of antigen
clustering, clustering of cell adhesion receptors, alterations in
the cytoskeleton, and/or defective recruitment of down-
stream effector molecules using confocal imaging of peptide-
specific immune synapses between DO11.10-Tg T cells and
peptide-loaded APCs. Loss of Carma1 expression had no
apparent effect on conjugation of DO11.10-Tg T cells with
peptide-pulsed APCs (Fig. 2 A). Lipid raft clustering as well
as TCR clustering and recruitment of TCRs to lipid rafts at
the T cell–APC interfaces were also comparable between
DO11.10-Tg/Carma1 /  and control DO11.10-Tg/Carma1 / 
T cells (Fig. 2, A and D). Moreover, F-actin (Fig. 2, B and
D) as well as LFA-1 clustering (Fig. 2, C and D) at the
immune synapses were comparable between Carma1 /  and
Carma1 /  T cells.
To examine whether loss of Carma1 affects peptide-spe-
cific cell adhesion of T cells to APCs, CD4  T cells
from DO11.10-Tg/Carma1 /  and DO11.10-Tg/Carma1 / 
mice were mixed with A20 APCs loaded with OVA pep-
tide, and conjugate formations between T cells and APCs
were analyzed by FACS (Fig. 2, E–G). T cell–APC conju-
gate formation increased in the presence of specific peptide
as compared with controls, demonstrating that this peptide-
specific induction of cell adhesion is dependent on TCR-
mediated signaling. Importantly, T cells from DO11.10-
Tg/Carma1 /  formed conjugates with peptide-pulsed
APCs at doses (Fig. 2 F) and time courses (Fig. 2 G) com-
parable to that of DO11.10-Tg/Carma1 /  control T cells.
Thus, loss of Carma1 has no apparent affect on inside-out
signaling and peptide-specific cell adhesion between T cells
and APCs. Collectively, our results show that Carma1 is
not required for peptide-induced immune synapse forma-
tion at the T cell–APC contact sites.
Carma1 Is Required for Recruitment of IKK into the cSMAC.
In neurons, MAGUK family proteins are required for
synapse formation and function as scaffolds for the assembly
of signaling complexes and cytoskeletal components at
cell–cell contact sites (12). It has been shown previously
that Carma1 is an essential component in the TCR-medi-
ated NF- B activation pathway (15, 16, 38, 41). Because
immune synapse formation appeared normal in DO11.10-
Tg/Carma1 /  T cells, we determined whether the loss of
Carma1 expression affects the recruitment of defined
downstream signaling molecules involved in the NF- B
activation pathway to the immune synapse. Moreover, we
wanted to determine whether the segregation of the im-
mune synapse into defined cSMAC and pSMAC subre-
gions occurred in the absence of Carma1 expression (1, 2).
Because it has been suggested that NF- B activation by
PKC  and IKK is regulated by their recruitment into lipid
rafts at the immune synapse (25, 33, 34), we first examined
the recruitment of these molecules after stimulation with
peptide-pulsed APCs (Figs. 3 and 4). When T cells were in-
cubated with control APCs, PKC  and IKK were localized
in the cytoplasm and did not colocalize with GM-1–con-
taining lipid rafts in both Carma1 /  and Carma1 /  T cells
(Figs. 3 A and 4 A). After conjugation of DO11.10-Tg/
Carma1 /  T cells with OVA peptide–pulsed APCs, PKC 
and IKK translocated to the T cell–APC contact sites (Figs.
3 A and 4 A). Localization experiments with GM-1 rafts to
visualize cSMACs (5) and LFA-1 to mark pSMAC (1, 2) re-
gions showed that PKC  was confined to the cSMAC area
and colocalized with the clustered GM-1 lipid rafts. Al-
though IKK can be detected in both cSMAC and pSMAC
subregions, IKK preferentially segregated into the cSMAC
area and colocalized with the clustered GM-1 lipid rafts
(Figs. 3 B and 4, B and C). Similar to control T cells, pep-
tide-mediated stimulation of DO11.10-Tg/Carma1 /  T
cells resulted in the recruitment of PKC  to the immune
synapse (Fig. 3 A). Moreover, in DO11.10-Tg/Carma1 / 
T cells, PKC  colocalized with GM-1 lipid rafts at the
cSMAC of the immune synapse and formed typical cSMAC
and pSMAC structure characterized by central PKC 
surrounded by a peripheral LFA-1 ring (Fig. 3 B and Fig.
S1, available at http://www.jem.org/cgi/content/full/
jem.20032246/DC1). Intriguingly, although IKK translo-
cated to the focal contact sites, colocalization of IKK with
lipid rafts at the cSMAC of the immune synapse was mark-
edly decreased in DO11.10-Tg/Carma1 /  T cells (Fig. S1).
Z axis analysis of the T cell–APC interface revealed that
IKK and lipid rafts were indeed spatially segregated at the
contact area of DO11.10-Tg/Carma1 /  T cells (Fig. 4 B).
Moreover, although PKC  and IKK colocalize at the
cSMAC region in Carma1-expressing T cells, IKK was re-
tained in the pSMAC area and did not colocalize with
PKC  at the cSMAC in DO11.10-Tg/Carma1 /  T cellsCarma1 Controls IKK Recruitment into cSMAC 1172
(Fig. 4, B–D). This segregation of lipid rafts and IKK at im-
mune synapses between Carma1 /  T cells and APCs fol-
lowed a typical pattern: clustered lipid rafts and PKC  at the
cSMAC are surrounded by LFA-1 and IKK in the pSMAC
areas (Fig. 4, B and C). Together, these results indicate that
Carma1 is dispensable for translocation of PKC  and IKK to
the focal contact sites between DO11.10-Tg T cells and
peptide-loaded APCs, but Carma1 is essential to recruit the
IKK complex to the cSMAC of the immune synapse where
PKC  localizes.
Carma1 Regulates IKK Recruitment to Lipid Rafts Down-
stream of PKCs. Because IKK can be recruited to lipid rafts
after PKC stimulation (33, 41, 42) and we observed normal
PKC  but defective IKK recruitment into lipid rafts and
cSMACs at immune synapses in Carma1 /  T cells, we
wanted to analyze whether Carma1 mediates IKK recruit-
ment and NF- B activation downstream of PKCs. We
stimulated primary Carma1 /  and Carma1 /  T cells with
PMA/ionophore and lipid raft cross-linking. It should be
noted that PMA/ionophore alone or lipid raft cross-linking
alone does not lead to effective raft aggregation nor PKC 
membrane recruitment (not depicted), suggesting that both
raft cross-linking and PKC activation are required for effi-
cient raft aggregation in primary T cells. In nonstimulated
Carma1 /  and Carma1 /  T cells, IKK and PKC  were lo-
cated in the cytoplasm (Fig. 5, A and B). In PMA/iono-
Figure 3. Normal SMAC seg-
regation and recruitment of PKC 
to cSMACs in Carma1 /   T
cells. (A and B) CD4  T cell blasts
from DO11.10 Tg/Carma1 / 
and DO11.10 Tg/Carma1 / 
were incubated with 10 6  M
OVA323–339  peptide–pulsed or
nonpulsed control A20 APCs
and incubated for 30 min. Images
of T cell–A20 conjugates and lo-
calization of GM-1–associated
lipid rafts (detected by CTx; A
and B, green) and PKC  (A and
B, red) and LFA-1 (B, blue) are
shown. Yellow in the merged
images indicates colocalization of
PKC  with lipid rafts. Localiza-
tion of PKC   at the immune
synapse interface is also shown in
B. (B, right) The histograms of
relative fluorescence intensity of
indicated molecules by scanning
along the white arrows indi-
cated in the merged left panels.
T, T cell; A20, A20 APCs.Hara et al. 1173
phore-stimulated cells, lipid raft clustering and recruitment of
PKC  to the lipid raft aggregates were comparable between
Carma1 /  and Carma1 /  T cells (Fig. 5 A). Thus, similar to
peptide-mediated immune synapse formation at the T cell–
APC interface (Fig. 3), lack of Carma1 does not affect PKC 
recruitment in response to PMA/ionophore stimulation.
Consistent with a previous report in cell lines and human
T cells (33), PMA/ionophore stimulation of Carma1 /  T
cells resulted in redistribution of IKK to the plasma mem-
brane and the formation of IKK clusters (Fig. 5 B). How-
ever, in the absence of Carma1, clustered IKK molecules
were again excluded from the lipid raft aggregates (Fig. 5
B). Importantly, although almost 100% of Carma1 /  T
cells showed colocalization of IKK with aggregated GM-1–
containing lipid rafts, in Carma1 /  T cells we could not
find any cells that colocalize IKK and GM-1–containing
lipid rafts by microscopic analysis. Similar to the T cell–
APC interface in Carma1 /  T cells (Fig. 4), z axis analysis
of  Carma1 /  T cells showed that IKK aggregates were
again spatially segregated from lipid rafts (Fig. 5 B). In both
experimental settings, IKK forms cluster and surrounds
GM-1–containing lipid raft aggregates, but does not local-
ize inside the GM-1  lipid rafts.
Because it has been reported that Carma1 /  T cells are
defective in recruitment of Bcl10 to lipid rafts after TCR
stimulation and CTx cross-linking (15), we tested whether
Bcl10 recruitment is also impaired after PMA/ionophore
stimulation. Bcl10 was recruited to the plasma membrane
and colocalized with lipid rafts in Carma1 /  T cells. In
contrast, recruitment and redistribution of Bcl10 to clus-
Figure 4. Carma1 is essential
for recruitment of IKK into
cSMACs and colocalization with
PKC . (A and B) T cell–APC
conjugates were formed as de-
scribed in Fig. 3. Localization of
GM-1–associated lipid rafts (A and
B, green) and IKK /  (A and B,
red) and LFA-1 (B, blue) are
shown. Yellow in the merged
images indicates colocalization of
IKK with lipid rafts. Localization
of IKK /  at the immune syn-
apse interface is also shown in B.
IKKs localize to the immune syn-
apse, but IKK molecules are ex-
cluded from lipid rafts in cSMACs
in Carma1 /  T cells. (B, right)
Histograms of relative fluores-
cence intensity of indicated mol-
ecules by scanning along the white
arrows shown in the merged
panels. (C) T cell–APC conjugates
were labeled with antibodies for
PKC   (green) and for IKK 
(red). The immune synapse in-
terfaces are shown. Yellow in the
merged images indicates colocal-
ization of PKC  with IKK . Note
that in Carma1-expressing T cells,
IKK /  as well as IKK  redistrib-
ute to the cSMAC area, whereas
in Carma1 /  T cells, IKK / 
and IKK  molecules move to the
contact areas, but are excluded
from cSMACs where PKC  mol-
ecules are located. (D) Percentages
of the immune synapses that dis-
play colocalization of IKK  with
PKC  at the cSMAC of the im-
mune synapse. At least 100 cells
were counted for each sample.
Results are representative of three
independent experiments.Carma1 Controls IKK Recruitment into cSMAC 1174
tered lipid rafts did not occur in Carma1 /  T cells (Fig. 5
C). However, although PMA/ionophore stimulation of
Carma1 /  T cells results in the formation of IKK clusters,
albeit clustered IKK molecules are excluded from the lipid
rafts (Fig. 5 B), Bcl10 did not translocate to the plasma
membrane and remained localized throughout the cyto-
plasm (Fig. 5 C). These results indicate that Carma1 con-
trols recruitment of both IKK and Bcl10 into lipid rafts, but
their recruitment is likely to be regulated differently.
Defective IKK Activation in Carma1 /  T Cells. To fur-
ther confirm impaired raft recruitment of IKK in Carma1 / 
T cells, we isolated detergent-soluble membrane and cy-
tosolic (S) and lipid raft–containing DIM fractions (33).
Consistent with our confocal microscopy studies, in both
Carma1 /  and Carma1 /  T cells, PKC  translocated from
the S fraction into DIM fractions after PMA/ionophore
stimulation, and the ratio of DIM/S fractions was in-
creased by three to four times (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20032246/DC1). IKK
was detected in S fractions as well as DIM fractions at simi-
lar levels in unstimulated Carma1 /  and  Carma1 /  T
cells. After stimulation of Carma1 /  T cells, the amount of
IKK in the S fractions was decreased and consequently the
DIM/S ratio was markedly increased, indicating that IKK
translocates from S into DIM fractions. In Carma1 /  T
cells, however, the amount of IKK in S fractions did not
change after stimulation (Fig. S2). Because it has been
shown that IKK recruitment to lipid rafts is important for
activation (33, 34) and our results indicated that IKK lipid
raft recruitment is defective in Carma1 /  T cells, we eval-
uated IKK function by in vitro kinase activity. In parallel
with defective recruitment of IKK to the lipid rafts, IKK
Figure 5. Carma1 controls
IKK and Bcl10 recruitment into
aggregated lipid rafts and IKK
activation downstream of PKCs.
(A–C) Activation-induced PKC ,
IKK, and Bcl10 redistribution to
aggregated lipid rafts. Purified
lymph node T cells from
Carma1 /  and Carma1 /  mice
were labeled with Alexa Flour
488 CTx and left untreated (con-
trol) or stimulated with 50 ng/ml
PMA/100 ng/ml calcium iono-
phore plus cross-linking of rafts
with 4  g/ml anti-CTx. Lipid
raft (green), PKC  (A, red),
IKK /  (B, red), and Bcl10 (C,
red) localization was analyzed 10
min after stimulation. Yellow in
the merged images indicates
colocalization of the indicated
molecule with GM-1–expressing
lipid rafts. Note that IKK / 
molecules are redistributed after
stimulation, but are excluded
from lipid rafts in Carma1  /  T
cells (x, y, and z axes are shown).
IKK /  localization was deter-
mined with an antibody that reacts
to both IKK  and IKK . Results
are representative of three inde-
pendent experiments. (D) Defec-
tive IKK activation in Carma1 / 
T cells. Purified lymph node T
cells were stimulated with 50
ng/ml PMA and 50 ng/ml cal-
cium ionophore, and IKK activ-
ity was determined by in vitro
immunocomplex kinase assays.
GST-I B   (amino acids 1–54)
was used as a specific substrate.
Levels of total IKK /  using an
antibody reactive to both IKK 
and IKK  are indicated. Results
are representative of three inde-
pendent experiments.Hara et al. 1175
activation after PMA/ionophore stimulation was signifi-
cantly impaired in Carma1 /  T cells (Fig. 5 D). Thus, ge-
netic inactivation of Carma1 abolishes stimulation-depen-
dent IKK recruitment to lipid rafts and IKK activation.
Discussion
It has been shown previously that T cells from Carma1 / 
mice have a severe defect in both proliferation and IL-2
production when stimulated with CD3 /CD28 cross-link-
ing or PMA/ionophore (15–17). Interestingly, our results
here showed that Carma1 is dispensable for proliferation
when T cells are stimulated with APCs pulsed with high
peptide doses, although at the same peptide concentration
Carma1 is essential for cytokine production. Stimulation of
T cells using CD3 /CD28 cross-linking is critically differ-
ent from that of peptide-pulsed APCs. For instance, APCs
express a variety of costimulatory and adhesion molecules
and produce cytokines that promote T cell–APC interac-
tion and enhance TCR signaling (43–45). Moreover, cog-
nate interactions between T cells and APCs increase and
induce the expression of molecules on both cells that then
amplify antigen receptor signaling.
Our data using a peptide–APC system show that Carma1
does not simply determine an all or nothing response as
previously reported, but under physiological stimulation
conditions Carma1 sets the threshold for T cell prolifera-
tion. Importantly, on the other hand, signals required for
cytokine production definitely depend on Carma1 expres-
sion. This differential requirement of Carma1 may explain
the in vivo T cell phenotype in Carma1 /  mice. Carma1-
deficient mice show normal numbers and development of
thymocytes and normal populations of peripheral T cells in
lymph nodes and spleen (15–17), indicating that loss of
Carma1 does not affect thymocyte expansion during devel-
opment, thymocyte selection, or homeostatic expansion of
peripheral T cells in vivo. In contrast, Carma1 /  mice
show impaired T-dependent immunity in vivo, which is
consistent with the abrogated cytokine production of
Carma1 /  T cells observed in our study. Thus, our find-
ings provide a novel aspect of Carma1-mediated TCR sig-
naling in T cell homeostasis and T cell activation. Whether
compensatory cytokine production in the absence of
Carma1 could drive proliferation of these cells needs to be
determined. Moreover, it would be interesting to elucidate
whether Carma1 might control localized cytokine secre-
tion at the focal contact site.
The nervous system and immune system use specialized
cell surface contacts to transduce signals between their con-
stituent cell populations (4). These two synaptic junctions
in neurons and lymphocytes share common structural fea-
tures. In neurons and epithelial cells, MAGUK family pro-
teins such as CASK, DLG, or PDS-95 have been shown to
assemble receptors, cytoskeletal components, and signaling
molecules at sites of cell–cell contact, including synapses,
cellular junctions, and polarized membrane domains
(13, 46). Carma1 is a lymphocyte-specific member of the
MAGUK family of proteins and is an essential component
required for TCR- or B cell receptor–induced lymphocyte
activation. Thus, Carma1 was predicted to be a candidate
molecule for the assembly and/or organization of supramo-
lecular signaling complexes in lymphocytes.
Using the DO11.10 immune synapse formation system,
our data show that loss of Carma1 does not typically affect
features of immune synapses at the T cell–APC interface.
DO11.10-Tg/Carma1 /  T cells display normal antigen re-
ceptor clustering, lipid raft clustering, integrin clustering, as
well as reorganization of filamentous actin at the focal con-
tact sites. Importantly, inactivation of Carma1 also did not
affect the normal segregation of the immune synapse into
cSMACs and pSMACs. Consistent with normal surface re-
ceptor clustering and cytoskeletal reorganization, conjugate
formation and peptide-induced adhesion between T cells
and APCs were also found to be comparable between
DO11.10-Tg/Carma1 /  and DO11.10-Tg/Carma1 /  T
cells. Our experiments refute the hypothesis that Carma1
functions as a scaffold that assembles multiple surface recep-
tors and the actin cytoskeleton at the synapse. Another
MAGUK family protein, the human lymphocyte homo-
logue of the Drosophila discs large tumor suppressor protein,
has also been implicated in T cell activation and is recruited
to SMACs upon CD2 cross-linking (47). Whether MAGUK
family proteins other than Carma1 are indeed essential for
immune synapse formation needs to be determined. Im-
portantly, our data provide the first genetic evidence on a
new class of molecular scaffold essential for the selective re-
cruitment of IKK into lipid rafts and spatial segregation of
IKK into the cSMAC at immune synapses.
PKC , Carma1, Bcl10, and IKK are all essential compo-
nents in the TCR-induced NF- B activation pathway
(15–18, 27–29). Although understanding of this pathway
has progressed rapidly, the molecular and structural rela-
tionship between these molecules still remains unsolved. It
has been suggested that PKC , Bcl10, and IKK are located
in the cytoplasm in resting cells and these molecules trans-
locate to lipid rafts at the immune synapse after TCR acti-
vation (33, 34, 38). Carma1 is located in both the cyto-
plasm and lipid rafts in resting T cells and the amount of
Carma1 in lipid rafts is increased after antigen receptor acti-
vation. Moreover, kinase activation of IKK is regulated by
the recruitment into lipid rafts, but the molecule(s) that
mediates the recruitment was not clear. Because previous
reports showed that PKC  physically associates with the
IKK complex in lipid rafts after TCR stimulation (33), the
same molecular mechanism that regulates PKC  recruit-
ment was a potential candidate pathway to also mediate the
recruitment of IKK. However, our data clearly show that
Carma1 acts downstream of PKCs in the recruitment of
IKK into aggregated lipid rafts. In addition, Carma1 is es-
sential for the recruitment of IKK, but not PKC , into
lipid rafts at the immune synapse. Consistent with this no-
tion, a recent report has shown that Carma1 can physically
interact with IKK  (48). Thus, Carma1 is an essential mo-
lecular adaptor that controls IKK recruitment into lipid
rafts and cSMACs downstream of immune synapse forma-
tion and PKC activation. Our results also demonstrate thatCarma1 Controls IKK Recruitment into cSMAC 1176
activation-induced recruitment of PKC  and IKK into lipid
rafts are separately regulated.
It has been proposed that Bcl10 is the molecule that acts
upstream of IKK and may recruit IKK to membranes (38).
Our data here and a recent report by Egawa et al. (15) have
shown that Carma1 is indeed essential for the recruitment of
Bcl10 into lipid rafts. Importantly, although Bcl10 does not
translocate to plasma membrane at all and remains distrib-
uted in the cytoplasm after TCR activation in Carma1 /  T
cells, IKKs translocate to the membrane region after stimu-
lation and form aggregates at the immune synapse or PMA/
ionophore-induced receptor caps, but does not enter into
the lipid rafts. Thus, although the same molecule, Carma1,
regulates the recruitment of both IKK and Bcl10 to lipid
rafts, our data suggest that the underlying mechanisms of re-
cruitment are different. Carma1 not only regulates translo-
cation of Bcl10 to the membrane, but also lipid raft recruit-
ment of Bcl10. In contrast, translocation of IKK from the
cytoplasm to the focal contact sites at the immune synapse
does occur in Carma1 /  T cells, but Carma1 is essential for
the recruitment of the IKK complex into aggregated GM-1
lipid rafts and the cSMAC. Based on our results, we propose
that Bcl10 is required for IKK activation in the lipid rafts.
Alternatively, Bcl10 recruitment into lipid rafts through
Carma1 might be the prerequisite for the translocation of
the IKK complex into GM-1–containing rafts and cSMAC.
For a model of Carma1-regulated IKK and Bcl10 re-
cruitment and activation, see Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20032246/DC1.
In conclusion, we have found that Carma1 has no appar-
ent role in the formation of the immune synapse, PKC  re-
cruitment, lipid raft aggregations, cSMAC and pSMAC
segregation, or activation-dependent cell adhesion. Carma1
acts downstream of immune synapse formation and PKC
activation and controls stimulation-dependent IKK recruit-
ment into the cSMAC of the immune synapse, thereby
regulating IKK activation. Moreover, Carma1 was found
to be essential for cytokine production, but set the activa-
tion threshold for proliferation in peptide-activated T cells.
Our data establish the molecular hierarchies by which dif-
ferent components of the NF- B activation pathway are
recruited into defined areas of the immune synapse. More-
over, these results elucidate the structural complexities by
which the adaptor Carma1 couples antigen receptor signal-
ing to IKK and NF- B activation in T cells.
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